Bank Of New York Mellon Corp Aldeyra Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$2.77 - $4.22 $25,489 - $38,832	-9,202 Reduced 5.41%	160,837 $526 Million
Q4 2023 Jan 29, 2024	SELL	$1.47 - $6.06 $10,766 - $44,383	-7,324 Reduced 4.13%	170,039 $597 Million
Q3 2023 Oct 24, 2023	SELL	$6.11 - $8.16 $1,429 - $1,909	-234 Reduced 0.13%	177,363 $1.18 Billion
Q2 2023 Aug 03, 2023	BUY	$7.11 - $11.89 $791,300 - $1.32 Million	111,294 Added 167.86%	177,597 $1.49 Billion
Q1 2023 May 09, 2023	BUY	$5.77 - $9.93 $382,568 - $658,388	66,303 New	66,303 $658 Million
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $335,483 - $468,223	66,040 New	66,040 $459,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $7.74 $46,561 - $94,838	-12,253 Reduced 15.61%	66,222 $354,000
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $319,156 - $636,999	-131,340 Reduced 62.6%	78,475 $314,000
Q1 2022 May 11, 2022	BUY	$3.25 - $5.17 $73,931 - $117,607	22,748 Added 12.16%	209,815 $932,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $9.63 $11,403 - $31,374	3,258 Added 1.77%	187,067 $749,000
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $303,244 - $431,951	-38,192 Reduced 17.2%	183,809 $1.61 Million
Q2 2021 Aug 11, 2021	BUY	$10.44 - $14.85 $1.82 Million - $2.59 Million	174,647 Added 368.81%	222,001 $2.52 Million
Q1 2021 May 13, 2021	SELL	$6.53 - $14.42 $60,859 - $134,394	-9,320 Reduced 16.44%	47,354 $562,000
Q4 2020 Feb 09, 2021	BUY	$6.31 - $8.13 $259,505 - $334,354	41,126 Added 264.51%	56,674 $388,000
Q2 2020 Aug 12, 2020	SELL	$1.97 - $5.05 $100,954 - $258,792	-51,246 Reduced 76.72%	15,548 $64,000
Q1 2020 May 06, 2020	SELL	$1.62 - $6.4 $12,090 - $47,763	-7,463 Reduced 10.05%	66,794 $164,000
Q4 2019 Feb 14, 2020	SELL	$4.73 - $7.98 $15,561 - $26,254	-3,290 Reduced 4.24%	74,257 $431,000
Q3 2019 Nov 07, 2019	BUY	$4.41 - $6.12 $9,675 - $13,427	2,194 Added 2.91%	77,547 $408,000
Q2 2019 Aug 12, 2019	BUY	$6.0 - $9.0 $32,436 - $48,654	5,406 Added 7.73%	75,353 $452,000
Q1 2019 May 14, 2019	SELL	$7.14 - $9.85 $495,216 - $683,176	-69,358 Reduced 49.79%	69,947 $631,000
Q4 2018 Feb 11, 2019	BUY	$7.26 - $13.29 $67,445 - $123,464	9,290 Added 7.15%	139,305 $1.16 Million
Q3 2018 Nov 09, 2018	BUY	$6.8 - $14.35 $545,176 - $1.15 Million	80,173 Added 160.85%	130,015 $0
Q2 2018 Aug 06, 2018	BUY	$6.95 - $9.18 $201,904 - $266,688	29,051 Added 139.73%	49,842 $396,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.9 $15,805 - $21,475	2,413 Added 13.13%	20,791 $156,000
Q4 2017 Feb 09, 2018	BUY	$5.7 - $7.75 $104,754 - $142,429	18,378	18,378 $125,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$44.4 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$26.2 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$17.3 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.01 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account